Loading…
Fresenius Medical Care AG is projected to rise to $30.56 by 2027, a +27% move from its current price of $24.02. FMS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $23.70 | $24.03 | $24.37 | +0.04% |
| Jul 14 | $23.57 | $24.04 | $24.52 | +0.09% |
| Jul 15 | $23.48 | $24.05 | $24.64 | +0.13% |
| Jul 16 | $23.40 | $24.06 | $24.74 | +0.17% |
| Jul 17 | $23.33 | $24.07 | $24.83 | +0.22% |
| Jul 18 | $23.28 | $24.08 | $24.92 | +0.26% |
| Jul 19 | $23.22 | $24.09 | $25.00 | +0.30% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $23.22 | $24.09 | $25.00 | +0.30% |
| Week 2 | $22.94 | $24.17 | $25.46 | +0.61% |
| Week 3 | $22.74 | $24.24 | $25.83 | +0.91% |
| Week 4 | $22.59 | $24.31 | $26.17 | +1.22% |
| Week 5 | $22.46 | $24.39 | $26.48 | +1.52% |
| Week 6 | $22.35 | $24.46 | $26.77 | +1.83% |
| Week 7 | $22.26 | $24.53 | $27.04 | +2.14% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments.
It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents.
The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
Fresenius Medical Care AG is a healthcare company focused on dialysis services and related products. Current price is $23.45 and the market cap stands at $12.6B, with a rank of 807. The near-term outlook reflects a neutral stance, with the 2026 forecast showing a min of $20.19, an avg of $23.45, and a max of $31.79.
This sets a starting point for the longer-run bull case that unfolds in subsequent years.
A major floor 19.8% below — a decisive break under it would weaken the trend.
The nearest floor, 14.4% below — buyers have tended to step in here.
Price is pressing into resistance (0.7% away) — a breakout level to watch.
A major ceiling 10.6% above — clearing it would confirm fresh momentum.
Key FMS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of FMS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $23.94 | Buy | $23.86 | Buy |
| MA 10 | $23.46 | Buy | $23.65 | Buy |
| MA 20 | $23.43 | Buy | $23.32 | Buy |
| MA 50 | $22.43 | Buy | $22.86 | Buy |
| MA 100 | $22.70 | Buy | $22.89 | Buy |
| MA 200 | $23.53 | Buy | $23.30 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.69 | Neutral |
| Stoch RSI (14) | 78.34 | Neutral |
| CCI (20) | 99.06 | Neutral |
| Williams %R (14) | -11.32 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | 1.35 | Buy |
| Bollinger %B (20,2) | 0.80 | Neutral |
| Stochastic %K (14) | 88.68 | Sell |
| TRIX (15) | 0.24 | Buy |
| Awesome (5,34) | 1.23 | Buy |
| Ultimate (7,14,28) | 73.78 | Sell |
| Momentum (10) | 0.77 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 24.25 | Sell |
| ADX (14) | 17.33 | Neutral |
| ATR (14) | 0.29 | Info |
The near-term technical picture is bullish. RSI14 is 60, indicating room for upside momentum while not yet overbought. The stock trades around the SMA50 of $22.27 and slightly below the SMA200 of $23.66, with a defined support at $20.19 and resistance at $23.45. The 30-day range runs from $20.95 to $26.25, framing the immediate price corridor.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $20.19 | $24.02 | $31.90 | 0% | Neutral | |
| $25.03 | $30.56 | $39.01 | +27% | Bullish | |
| $30.04 | $37.37 | $49.00 | +56% | Bullish | |
| $35.13 | $44.38 | $59.42 | +85% | Bullish | |
| $38.03 | $48.68 | $66.36 | +103% | Bullish | |
| $40.61 | $52.62 | $72.86 | +119% | Bullish | |
| $42.27 | $55.39 | $77.79 | +131% | Bullish | |
| $46.56 | $61.65 | $87.70 | +157% | Bullish | |
| $55.30 | $73.96 | $106.47 | +208% | Bullish | |
| $61.08 | $82.46 | $120.03 | +243% | Bullish | |
| $82.04 | $115.52 | $176.21 | +381% | Bullish | |
| $173.34 | $261.78 | $428.03 | +990% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $20.19 | $24.02 | $28.53 | +0.00% |
| August 2026 | $20.63 | $24.14 | $28.87 | +0.52% |
| September 2026 | $21.24 | $24.98 | $30.11 | +3.48% |
| October 2026 | $22.01 | $25.99 | $31.53 | +4.04% |
| November 2026 | $21.96 | $26.02 | $31.74 | +0.11% |
| December 2026 | $21.89 | $26.02 | $31.90 | -0.01% |
Click any year to see its month-by-month FMS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect FMS to range from $20.19 to $31.90 through 2026. The $24.02 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The FMS price prediction for 2027 points to an average of $30.56 (low $25.03, high $39.01) — a potential gain of +27% on today's $24.02. Momentum favours further upside here.
In 2028, FMS is projected to trade between $30.04 and $49.00, averaging $37.37 — a potential gain of +56% from today's $24.02. That is up +22% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Fresenius Medical Care AG's 2029 outlook centres on $44.38, within a $35.13 to $59.42 range. That is up +19% on the projected 2028 average. That marks a +85% change versus current levels. Momentum favours further upside here.
By 2030, FMS could reach as high as $66.36, with a base case around $48.68 and support toward $38.03 — roughly +103% from $24.02. Buyers look set to stay in control over this stretch.
Expect FMS to range from $40.61 to $72.86 through 2031. The $52.62 average target implies a +119% move from current prices. That is up +8% on the projected 2030 average. Momentum favours further upside here.
The FMS price prediction for 2032 points to an average of $55.39 (low $42.27, high $77.79) — a potential gain of +131% on today's $24.02. Buyers look set to stay in control over this stretch.
In 2033, FMS is projected to trade between $46.56 and $87.70, averaging $61.65 — a potential gain of +157% from today's $24.02. That is up +11% on the projected 2032 average. Momentum favours further upside here.
Fresenius Medical Care AG's 2034 outlook centres on $73.96, within a $55.30 to $106.47 range. That is up +20% on the projected 2033 average. That marks a +208% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, FMS could reach as high as $120.03, with a base case around $82.46 and support toward $61.08 — roughly +243% from $24.02. Momentum favours further upside here.
Expect FMS to range from $82.04 to $176.21 through 2040. The $115.52 average target implies a +381% move from current prices. That is up +40% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The FMS price prediction for 2050 points to an average of $261.78 (low $173.34, high $428.03) — a potential gain of +990% on today's $24.02. Momentum favours further upside here.
Investing $1,000 in FMS today (≈ 41.631973 FMS) could be worth
$10,898.31
+$9,898.31 (+990%) by 2050 · US Dollar
Based on the average projected FMS price of $261.78 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in FMSwould be worth at today's price.
$1,000 invested in FMS on Jul 10, 2025 (≈ 36.429871 FMS) would be worth
$875.05
-$124.95 (-12.5%) today · 0.88× · US Dollar
Based on a FMS entry price of $27.45 vs. today's $24.02.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $23.53 | $1,020.82 | +2.1% |
| 1 month ago | $22.28 | $1,078.1 | +7.8% |
| 3 months ago | $23.63 | $1,016.5 | +1.7% |
| 6 months ago | $23.84 | $1,007.55 | +0.8% |
| 1 year ago | $27.45 | $875.05 | -12.5% |
| All time (5.0y) ago | $41.31 | $581.46 | -41.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our FMS forecast.
Our base-case forecast reaches $48.00 around 2030.
Implied market cap at $48.00: $25.78B
The multi-year forecast shows a progression from neutral in 2026 to bullish thereafter. For 2026 the avg is $23.45 with min $20.19, max $31.79 and ROI 0, sentiment NEUTRAL. From 2027 onward the outlook turns bullish, with 2027 avg $29.84, ROI 27.2; 2028 avg $35.74, ROI 52.4; 2029 avg $43.65, ROI 86.1; 2030 avg $46.36, ROI 97.7; 2031 avg $48.79, ROI 108; 2032 avg $53.94, ROI 130; 2033 avg $58.31, ROI 148.7; 2034 avg $68.43, ROI 191.8; 2035 avg $78.76, ROI 235.9.
The trajectory remains bullish into 2040 with avg $106.87, ROI 355.7, and into 2050 with avg $242.23, ROI 933. These are estimates and not guarantees, but the data show substantial long-run upside alongside rising average prices and ROIs.
Tap a question to reveal the answer.
Avg $46.36, min $36.18, max $63.27, ROI 97.7, sentiment BULLISH.
The 2027–2050 forecasts show bullish sentiment with rising averages and ROIs up to 933 by 2050, while 2026 is Neutral; these are estimates and not guarantees.
Yes. The 2040 forecast lists an avg of $106.87 with a max of $163.11, indicating the potential to exceed $100 by 2040.
Avg $242.23, min $160.32, max $396.24, ROI 933, sentiment BULLISH.
Fresenius Medical Care AG Community Discussion
0Share your Fresenius Medical Care AG price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.